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Obstructive lesions of the inferior vena cava:
Clinical features and endovenous treatment
Seshadri Raju, MD, Kathryn Hollis, BA, and Peter Neglen, MD, PhD, Flowood, Miss
Objective: Chronic obstructions of the inferior vena cava (IVC) are associated with many odd features. Even total
occlusions may remain entirely silent or present late with acute symptoms. Renal dysfunction is rare. Many have chronic
symptoms, but often only one limb is affected. We describe the clinical features in a series of 120 patients seen over a
10-year period and the results of successful stent placement in 99 limbs.
Methods: Patients with acute onset of symptoms due to distal thromboses underwent catheter-directed thrombolysis.
Patients with significant chronic symptoms were investigated by duplex, venous function tests, transfemoral venography
and finally intravascular ultrasound (IVUS). Stenotic segments were balloon dilated and occluded segments were
recannalized when feasible; stents were placed under IVUS control.
Results: In the asymptomatic group, 10 patients with total occlusions had transient or no occlusive symptoms. In the acute
symptom group, four patients with chronic IVC occlusions presented with acute onset of deep venous thrombosis distal
to the occlusion but became asymptomatic when the clot was lysed. In the chronic symptom group, 97 patients (99 limbs)
had symptoms of chronic venous disease of variable distribution and intensity. In two-thirds, limb symptoms were
unilateral. Pathology was total occlusion in 14%, and the rest were stenoses. The lesion extended above the renal vein in
18%. Common iliac obstruction was concurrent in 93%. Distal reflux was present in 66%. Modifications of the basic stent
technique were required in recanalization of total occlusions (four extending up to the atrium), two bilateral stent
deployments, and nine IVC filter cases. Stent deployment across the renal and hepatic veins or the contralateral iliac vein
had no adverse sequelae. Stent patency (cumulative) at 2 years was 82%. Complete relief (cumulative) of pain and swelling
at 3.5 years was 74% and 51%, respectively. The cumulative rate of complete ulcer healing at 2 years was 63%. Overall
clinical outcome was rated as good or excellent in 70%.
Conclusions: The unusual clinical features of IVC obstructions seem related to the rich collateralization, which has an
embryonic basis. Common iliac vein patency seems to be a crucial link in collateral function, and its concurrent occlusion
produces symptoms. Percutaneous stent placement has an emerging role in the treatment of IVC obstructive lesions, with
good mid-term stent patency and clinical results. ( J Vasc Surg 2006;44:820-7.)Chronic obstructive lesions of the inferior vena cava
(IVC) are associated with many unusual features: many
have chronic symptoms, but some total occlusions may be
entirely silent.1-3 Some, having remained silent, present
acutely with the onset of distal thrombosis.4-9 Renal and,
less often, hepatic impairment are usually absent. Obstruc-
tive symptoms in the extremities may be surprisingly vari-
able in type and intensity, and often only one extremity is
affected. In this article, we describe the clinical features,
technique of stent placement, and mid-term results in a
group of cases with IVC stenosis or occlusions seen over a
10-year period.
MATERIALS AND METHODS
A total of 120 patients with IVC obstructions were
encountered from 1997 to 2005, representing 2.8% of
patients with chronic venous disease (n  4217) seen
during the same period. Stent placement was not offered in
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82014 patients because symptoms were mild, transient, or
absent to begin with (n  10) or abated (n  4) after
successful catheter-directed lysis of acute distal thrombus
below the chronic IVC obstruction. Stent placement was
recommended in the remaining 106 patients. Two patients
declined, and placement was successful in 97 patients (99
limbs: 2 bilateral, 14 occlusions, and 85 stenoses) and
unsuccessful in 7 (all occlusions). IVC stent placement (n
99) constituted 6% of all venous stent placements for
chronic venous disease during this period.
The female-male ratio was 2:1, and the left-right ratio
was also 2:1. The median age was 51 years (range, 14-80
years). Among patients treated with stent placement, limb
symptoms were bilateral in only 32 (33%) of 97 and were
unilateral in the remaining 65 (67%). Among all four
patients who developed acute symptoms with distal throm-
bosis below a chronically occluded IVC, symptoms were
unilateral. The CEAP clinical classification10 in stented
limbs (n  99) was as follows: C1, 2%; C2, 9%; C3, 37%;
C4, 26%; C5, 7%; and C6, 19%.
Pathology
Eighty-two percent (81/97) of the IVC lesions (n 
97) were infrarenal, 14% (14/97) were suprarenal below
the diaphragm, and 4% (4/97) extended further into the
thoracic IVC segment. The disease was limited to the IVC
proper only in 7% of patients. Distal extension into the
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into the distal common iliac vein in 22%, into the external
iliac vein in 37%, into the common femoral vein in 31%, and
further distally in 3%. IVC lesions were partial (60%
stenosis) in 86% and were total occlusions in 14%. Collat-
erals were uniformly present. In nine cases, an IVC filter
was present.
Reflux was present in 66 of 99 limbs, with axial reflux to
below the knee in 27 limbs. In 49 limbs, reflux involved two
or more venous segments. Among 19 limbs with ulcers,
reflux was present in 17, all involving both the superficial
and deep systems (axial in 10) except in one limb, for which
only the superficial system was involved.
Clinical features
Patients in this series fell into three clinical groups:
(1) asymptomatic, (2) acutely symptomatic, and (3) chron-
ically symptomatic.
Asymptomatic group. Ten patients in this series were
either totally asymptomatic or had only transient or cos-
metic symptoms with little functional impairment of the
limb. Several (n  7) sought clinical advice because of
limb, scrotal, or abdominal varices. Superficial thrombo-
sis of the abdominal varix was the presenting complaint
in two of these cases. Mild transient leg swelling, tran-
sient groin pain, and a transient ulcer were the mode of
presentation in one patient each. All were treated conser-
vatively for fear of producing overt limb pain and edema by
unwarranted surgical trauma in the context of trivial or
absent symptoms.
Acute symptom group. Four patients initially pre-
sented with acute deep venous thrombosis of the lower
extremity without prior leg symptoms. All four underwent
catheter-directed thrombolysis during which a chronically
occluded vena cava was discovered. After successful lysis of
the acute thrombus below the occluded IVC, all four pa-
tients became asymptomatic again. Three remained asymp-
tomatic, and the fourth patient developed limb symptoms
after recurrent distal thrombosis 5 years later.
Chronic symptom group. Symptoms were chronic in
99 limbs of 97 patients.
Assessment
The degree of swelling was assessed by physical exami-
nation (grade 0, none; grade 1, pitting, not obvious; grade
2, ankle edema; and grade 3, obvious swelling involving the
limb). The level of pain was measured by using the visual
analogue scale.11
Investigations
Patients underwent venous laboratory tests including
duplex scan, ambulatory venous pressure measurement
(percentage decrease; venous filling time), arm/foot pres-
sure test,12 air plethysmography (VFI90),
13 and contrast
studies. A valve closure time of longer than 0.5 seconds on
duplex scan was defined as reflux.Stent placement
Stent placement was offered to patients according to
symptom severity. Most belonged to CEAP class 3 or
higher. Five patients in class C1 and 2 received a stent
because of severe associated pain and six others to relieve
recurrent cellulitis (4) or recurrent superficial phlebitis (2).
Nineteen patients received stents because of active ulcer-
ation. In two patients, bilateral iliac vein stents were re-
quired in addition to IVC stenting.
Technique. Venous stent placement and recanalization
procedures have been described in detail elsewhere.14,15
Some modifications for special situations in IVC were
required.
Access was obtained through the femoral vein at the
midthigh level under ultrasound guidance with the patient
in the supine position. Sheaths ranging from 9F to 14F
were used as necessary. Traversing stenotic lesions is
straightforward. For recanalizations, Glidewires (Terumo
Medical Corporation, Somerset, NJ) of varying sizes, tip
angles, and stiffnesses were used in conjunction with sup-
porting catheters (angled or straight tips) as necessary to
traverse the occlusions. Because the Glidewire tip is floppy,
it invariably remains within the occluded venous structure.
The tough adventitia and perivenous fibrosis seem to pro-
vide natural resistance against perforations. Limited ex-
travasations of contrast can be safely ignored. Larger dye
extravasations (rare with experience) call for cessation of
the procedure, which can be reattempted a few weeks later.
After the lesion is crossed, further easy passage of the
Glidewire signifies proper IVC re-entry, which should be
confirmed by venography/intravenous ultrasonography
Fig 1. The stenosis/occlusion should be dilated to accommodate
a stent of approximately the same size as normal anatomy for
proper function (left). In rigid lesions and occlusions, overdilation
by 1 or 2 mm will allow for recoil. The Glidewire seldom strays
outside the occluded vein, and this can be confirmed by intrave-
nous ultrasonography after predilation (right). Dilation of up to 24
mm in the inferior vena cava has not resulted in clinical hemor-
rhage.(IVUS). Predilation up to 6 to 8 atm is generally adequate
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rigid lesions and total occlusions. Progressive dilation is
recommended in the latter case (Fig 1).
Wallstents (Boston Scientific, Natick, Mass) ranging
from 14 mm in the external iliac vein to 24 mm in the IVC
were used as appropriate to match the normal lumen size.
Generous overlap of at least 3 to 4 cm is necessary to avoid
“shelving” of the stent ends at curvature points and the
pelvic brim and to allow for stent shortening with postde-
ployment dilation. Intravenous ultrasonography is essential to
select the optimal proximal and distal landing sites for the
stent because disease often extends beyond that visible on
venography.16,17 All diseased segments should be covered by
the stent to ensure adequate inflow into and outflow from the
stent (Fig 2).
Filters, when present, were treated like rigid lesions and
pushed aside by balloon dilation up to 16 atm (Fig 3).
When both limbs are symptomatic with bilateral iliac vein/
IVC disease, Wallstents can be configured in the form of an
inverted Y (Fig 4).
A completion venogram and intravenous ultrasonogra-
phy are performed to assess proper positioning of the stents
and to ensure the absence of intrastent stenoses, thrombi,
or uncorrected proximal and distal lesions, all of which
should be corrected without hesitation. Prompt deploy-
ment of the stents and establishment of flow, once the
recanalized channel is predilated, is the key to avoid signif-
icant channel or intrastent thrombus formation. When
encountered, the thrombus can usually be squeezed out by
postdeployment balloon dilation. Rapid clearance of con-
trast through the stent and disappearance of collaterals is a
reliable indication of adequate stent function. Poor inflow,
when encountered, should be reassessed with a smaller (6F
or 7F) sheath, because larger sheaths can impede inflow.
Adjunctive A-V fistulas to increase inflow were not used.
Fig 2. A case in which there was segmental occlusion of the
inferior vena cava (IVC) at the renal level with additional diffuse
stenotic lesions involving infrarenal IVC and both iliofemoral veins
(left). The stents were extended into the thoracic IVC and distally
into the femoral veins bilaterally (right).We have routinely used sealing devices at the access site(Vasoseal, Datascope Corp, Montvale, NJ) because of the
mid-thigh access and the large sheath size needed.
The procedure was performed with patients under gen-
eral anesthesia on an outpatient basis (23-hour admission).
Patients were administered 5000 U of dalteparin before
surgery. The procedure was performed under intermittent
minimal heparin (1000-2000 U every 90 minutes). More
recently, bivalirudin (75-mg intravenous single dose) has
been satisfactorily substituted for heparin to further mini-
mize platelet activation. After surgery, patients received
dalteparin 5000 U subcutaneously every 12 hours for a
Fig 3. A case in which an inferior vena cava filter was pushed aside
and a stent was placed past the compacted stent. Nine filters of
various makes in common use, including types with prongs, were
successfully stented across (despite balloon punctures).
Fig 4. Stent placement at the inferior vena cava (IVC) bifurca-
tion: after the IVC stent is extended into one of the iliac veins, a
fenestrum is created by balloon dilation over a guidewire. The
guidewire is introduced through the opposite side and manipu-
lated through the stent. A generous overlap of 5 cm between the
stents is recommended to prevent the second stent from shrinking
back through the fenestrum during postdilation. No restriction of
either iliac flow has been observed when this technique has been
used.maximum of three doses or longer (4 days) if follow-up
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Warfarin was instituted in cases of thrombophilia and su-
prarenal stent extension and if patients were taking chronic
anticoagulation before surgery. Otherwise, patients were
placed on daily aspirin (81 mg).
Concurrent procedures
Twelve patients underwent saphenous ablation (radio-
frequency or laser) concurrent with the stent procedure.
Saphenous reflux in five patients was ignored either because
the vein was small (5 mm) in caliber or for technical
reasons (prolonged or complex stent procedure).
Reinterventions
There were 15 primary assisted (patent stent with re-
sidual symptoms) interventions in the follow-up period.
Nine patients underwent balloon dilation to relieve focal
stenoses compressing the stent; these seemed to be the
result of inadequate predilation during the original proce-
dure. In six others, extension of the stent proximally or
distally was required to correct missed lesions during the
original procedure.
Follow-up and outcome assessment
Patients were examined at 6 weeks and 3, 6, and 9
months after stent placement and at yearly intervals there-
after. Venography and venous laboratory tests were per-
formed during the first 6 months after stent placement and
then annually. Outcome was graded as recommended by
reporting standards.18
Data analysis
Clinical data were entered prospectively into a time-
stamped electronic medical records program for retrospec-
tive analysis. A commercially available statistical program
(GraphPad Prism for Windows, version 3.0; GraphPad
Software, San Diego, Calif) was used for statistical analysis.
Fig 5. Cumulative inferior vena cava (IVC) stent patency (pri-
mary assisted) confirmed by venography.Actuarial survival curves were constructed according to theKaplan-Meier method. Nonparametric Wilcoxon rank tests
for unpaired data and 2 analysis were used to compare
groups as appropriate. A P value of less than .05 was
considered significant.
RESULTS
Procedure success was 100% in stenotic lesions and 66%
(14/21) in occlusions; the latter includes 2 patients in
whom recanalization was successful only on the second
attempt. In five of seven patients in whom the procedure
failed, a minimum of two attempts were made before stent
placement was abandoned.
Periprocedure (30-day) mortality and late stent-related
mortality during the follow-up period were nil. There were
no pulmonary emboli. There was a transient postprocedure
creatinine increase (probably contrast related) in one pa-
tient, in whom recanalization had failed. There was no
instance of clinically apparent hemorrhage that necessitated
transfusions or volume replacement. There was no detect-
able renal or hepatic dysfunction in cases of suprarenal or
thoracic stent extensions, respectively. There were no ac-
cess site complications in this series. There were no malse-
quelae in patients in whom the procedure was unsuccessful
or aborted as a result of major contrast extravasations.
Postoperative mild to moderate back pain was a common
complaint in many patients (approximately 20%) and was
easily controlled by nonsteroidal analgesics; none necessi-
tated admission.
Follow-up was available in 92% (91/99) after stent
placement. The median follow-up was 11 months (range,
3-59 months).
Cumulative primary and primary assisted stent patency
were 58% and 82%, respectively, at 2 years (Fig 5). Four
stents had become occluded during the follow-up period:
two for correction of stenoses and two others for recanaliz-
Table. Venous function tests before and after stent
placement in inferior vena cava obstruction
Variable
Before surgery,
median (range)
After surgery,
median (range)*
Ambulatory venous pressure
Pressure drop (%) n  58 n  16
62.5 (1-100) 51.5 (28-90)†
Venous filling time (s) n  58 n  15
19 (3-120) 33 (6-160)†
Air plethysmography
VFI90 (mL/s) n  73 n  37
1.9 (0.1-11.9) 1.3 (0.2-5.4)†
Hand/foot—venous
pressure test
Hand/foot pressure
differential (mm Hg)
n  54 n  20
1 (0-15) 0 (0-7)†
Reactive hyperemia
pressure elevation
(mm Hg)
n  58
7 (0-29)
n  21
5 (2-23)†
*Latest available test.
†P  .0008.ing totally occluded segments. There was no worsening in
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placement (Table); reflux and obstructive indices actually
showed a slight improvement after surgery.
Preoperative pain was present in only 61 (61%) of 99
limbs, and the remainder were pain-free. Among limbs that
had limb pain before, 74% (cumulative) were completely
pain-free at 3.5 years after stent placement (Fig 6).
Preoperative swelling was present in 75 of 99 patients
and absent in the remainder. Among the limbs that had
swelling before, 51% (cumulative) were completely free of
swelling at 3.5 years after stent placement (Fig 7).
Among 19 with active ulcers, 12 (63%; cumulative)
healed and remained healed with complete epithelialization
at 2 years. Among the 12 healed ulcers, only 2 had concur-
rent saphenous ablation, meaning that ulcer healing in the
rest could be directly attributed to the stent procedure,
because the associated reflux remained uncorrected. Nine
limbs with ulcers that healed after stent placement had
untreated residual deep reflux (4/9 axial). All seven limbs
with unhealed ulcers had residual untreated reflux (six
axial).
The overall clinical outcome was graded as follows
according to the reporting standards (3, excellent; 2,
good; 1, mild improvement; 0, no improvement; and
1, worse):3, 43%;2, 27%;1, 16%; 0, 13%; and1,
1%. Thus, 70% of the limbs had an excellent or good clinical
outcome at the end of their follow-up period.
DISCUSSION
The fully developed IVC is a complex structure derived
from different segments of an array of multiple paired
longitudinal embryonic veins (at least four pairs) and the
interconnections between them.19,20 The development of
the IVC near the liver and diaphragm is particularly com-
plex, because new outgrowths from the hepatic veins and
the infrarenal IVC have to meet and establish a connection.
Fig 6. Cumulative complete relief of pain after inferior vena cava
(IVC) stent placement; partial pain relief was marked as failure and
censored. Only those who had preoperative pain were included.This area seems to be prone to developmental anomaliessuch as webs and strictures. Parts of the formative venous
network disappear or remain as embryonic rudiments;
other parts are recognizable in the adult as named struc-
tures, such as the azygos, hemiazygos, accessory hemiazy-
gos, and thoracolumbar veins. All interconnect with each
other to freely form a potentially rich collateral network.
The thoracolumbar vein receives drainage directly from the
common iliac vein through a large connection that is prom-
inent in cases of IVC obstruction (Fig 8). As embryonic
alternates to the IVC, growth of the retained named and
unnamed putative collateral veins can be expected to be
vigorous if the IVC failed to develop properly before birth
or occluded even later during the growth period. The
normal flow direction in these veins is the same as potential
collateral flow. These attributes probably provide for very
efficient collateral function, and the collaterals can be ap-
propriately termed natural collaterals. These may be so
dilated as to appear as a left-sided vena cava or double venae
cavae on venograms (Fig 9). Given the fact that the collat-
eral network in IVC obstructions receives drainage directly
or indirectly from the common iliac veins, the patency of
the latter vein seems to be crucial for the collateral network
to function effectively. Natural collaterals elsewhere with an
embryonic basis and natural flow direction also seem to
function efficiently.21 Tributary collaterals—main alternate
pathways in isolated iliac vein obstructions—seem to func-
tion less efficiently; collateral flow direction is opposite
normal. Many or most iliac vein occlusions seem to remain
symptomatic despite the presence of tributary collaterals on
venography.12 In cases of combined iliac/IVC obstruction,
collateral compensation is likely to be poor.
Many curious features of IVC obstructions/occlusions
can be explained on the basis of the aforementioned collat-
eral development. Approximately 10% in this series had no,
mild, or only transient symptoms. With widespread use of
imaging studies, the lesion is being detected in asymptom-
Fig 7. Cumulative complete relief of swelling after inferior vena
cava (IVC) stent placement; partial swelling relief was marked as
failure and censored. Only those who had preoperative swelling
were included.atic patients as an incidental finding during examination for
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congenital agenesis or atresias, even though early occlu-
sions could present a similar picture. The lack of symptoms,
including the nearly universal absence of renal or hepatic
dysfunction, in this subset is undoubtedly related to excel-
lent collateral development and function. Symptomatic
Budd-Chiari syndrome related to segmental IVC obstruc-
tions seems to behave differently in this respect; this may in
part be related to the concurrent involvement of hepatic
veins.24,25
There are scores of reports in the literature of previously
silent IVC obstructions presenting with symptomatic acute
distal deep venous thrombosis. For this reason, chronic
anticoagulation has been suggested when such silent le-
sions are found.2 There were four patients in this series with
such a presentation. All four became symptom-free with
lysis of the acute thrombus. This clinical pattern under-
scores the importance of the common iliac vein as the
primary outflow source for the collateral network in IVC
obstructions. Ninety-two of 99 symptomatic limbs that re-
ceived stent placement also had common iliac vein stenosis/
obstruction on the stented side. Ipsilateral common iliac
vein involvement also may explain why two-thirds of pa-
tients in this series had only unilateral symptoms in IVC
occlusions. In seven cases in this series, there was no com-
mon iliac vein involvement, and the lesion was entirely
confined to the IVC. In some of these cases, severe coex-
isting reflux could be responsible for symptom production.
Fig 8. Collaterals in a case of inferior vena cava obstruc
vein and the common iliac vein (left). Higher up, the th
drain into the right atrium (right).In 3 of 7 cases, stenotic lesions in the major collateral wereidentified. The critical lesion in the collateral in all three
cases was at or near the diaphragm, which could not be
traversed with a guidewire (Fig 10).
IVC lesions, particularly occlusions, are lengthy, and
there is an intuitive tendency to limit the length of stented
segments to minimize thrombosis from stent exposure.
Counterintuitively, our experience indicates otherwise.
Thrombosis of treated segments has been less related to the
metal load of the stents per se than to the violation of
established principles of vascular surgery: ensuring proper
inflow and outflow (correcting all lesions) and avoiding
technical defects related to the conduit (stent). In pursuit of
these principles, we have extended the stent above patent
renal veins, across contralateral iliac veins, and below the
inguinal ligament when necessary.14-16 There were no
thromboses of either the stent or the major tributary out-
flow in this series. The Wallstent seems to allow free flow of
the tributaries across the interstices of the stent. Crossing
the inguinal crease has not resulted in fracture or increased
stent thrombosis. Stent fracture in arteries at flexion points
may be related to metal fatigue from movement related to
arterial pulsations. There may be hesitation to dilate the
obstructive vein to the size recommended, but fears of
hemorrhage with rupture have not borne out in more than
1000 stent deployments (unpublished data). This is prob-
ably related to the comparatively low prevailing venous
pressure and the constraining influence of perivenous fascia
and retroperitoneal cover if rupture indeed occurs in some
Note the large connection between the thoracolumbar
olumbar vein feeds into the azygos network (center) totion.
oraccases. Imaging studies in the cases of common postopera-
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as an unlikely etiologic factor. They are no longer per-
formed on a routine basis. Compromising dilation to the
required size is likely to result in residual stenosis in the
stented segment, stent malfunction, or thrombosis.
We have learned that success or failure in recanalizing
total occlusions cannot be predicted by the extent of the
lesion or by its venographic appearance. One or more
attempts at reopening the occlusion are warranted in all
cases. We have been astonished at how even extensive
lesions can be traversed with some persistence and pa-
tience. Percutaneous stent placement is emerging as an
alternative to open surgery26 to correct IVC obstruc-
tions.27,28 Many of the technical challenges are solvable.
Mid-term stent patency with symptom relief is excellent.
The healing of stasis ulceration by stent placement alone,
even in the presence of significant untreated residual
reflux, has been previously reported.29 Stent placement
is an attractive option in treating IVC lesions because it is
minimally invasive and safe and seems to be effective at
least in the mid term. Also, later open surgery is not
precluded.
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